César Rivas-Santiago

Author

Universidad Autónoma de Zacatecas "Francisco García Salinas"ORCID

Also Known As

C E Rivas-Santiago, C Rivas-Santiago, C SANTIAGO, C. E. Rivas-Santiago, Carlos Cervero Santiago, Cesar E. Rivas Santiago, Cesar E. Rivas-Santiago, Cesar Enrique Rivas-Santiago, Cesar Rivas, Cesar Rivas Santiago

Publications

949

Citations

H-Index

Concepts

All Affiliations

Universidad Autónoma de Zacatecas "Francisco García Salinas"Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán Autonomous University of San Luis Potosí Instituto Nacional de Enfermedades Respiratorias Secretaría de Ciencia, Humanidades, Tecnología e Innovación

About

César Rivas-Santiago is an author at Universidad Autónoma de Zacatecas "Francisco García Salinas" specializing in immunology, medicine, and tuberculosis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	480
2	Allergy	2	2	212
3	Engineering	1	1	49
4	Health Sciences	1	1	38
5	Public Health	1	1	61

César Rivas-Santiago

Publications

842

Citations

H-Index

Page 1

	Year	Citations
Air Pollution Particulate Matter Alters Antimycobacterial Respiratory Epithelium Innate Immunity César Rivas-Santiago, Srijata Sarkar, Pasquale Cantarella, Infection and Immunity ImmunotoxicologyLung InflammationTuberculosis PreventionImmunologyAir Quality	2015	151
Activity of LL-37, CRAMP and antimicrobial peptide-derived compounds E2, E6 and CP26 against Mycobacterium tuberculosis Bruno Rivas‐Santiago, César Rivas-Santiago, Julio Enrique Castañeda‐Delgado, International Journal of Antimicrobial Agents Pulmonary TuberculosisMedicineMycobacterium TuberculosisImmunologyTuberculosis	2012	130
Ability of Innate Defence Regulator Peptides IDR-1002, IDR-HH2 and IDR-1018 to Protect against Mycobacterium tuberculosis Infections in Animal Models Bruno Rivas‐Santiago, Julio Enrique Castañeda‐Delgado, César Rivas-Santiago, PLoS ONE	2013	116
Induction of β-defensins by<scp>l</scp>-isoleucine as novel immunotherapy in experimental murine tuberculosis César Rivas-Santiago, Bruno Rivas‐Santiago, Diana Aguilar León, Clinical & Experimental Immunology	2011	76
Passive administration of purified secretory IgA from human colostrum induces protection against Mycobacterium tuberculosis in a murine model of progressive pulmonary infection Nadine Álvarez, Oscar Otero, Frank Camacho, BMC Immunology	2013	62
Season and size of urban particulate matter differentially affect cytotoxicity and human immune responses to Mycobacterium tuberculosis Srijata Sarkar, César Rivas-Santiago, Olufunmilola Ibironke, PLoS ONE AsthmaHuman Immune ResponsesOccupational Health SciencesTuberculosis PreventionImmunology	2019	61
Modulation of Human Macrophage Responses to Mycobacterium tuberculosis by Silver Nanoparticles of Different Size and Surface Modification Srijata Sarkar, Bey Fen Leo, Claudia Carranza, PLoS ONE NanoparticlesNanotherapeuticsEngineeringMicrobial PathogensImmunotoxicology	2015	49
Lipid Metabolism Alterations in a Rat Model of Chronic and Intergenerational Exposure to Arsenic César Rivas-Santiago, Irma González-Curiel, Sergio Zarazúa, BioMed Research International	2019	41
Kinetics and cellular sources of cathelicidin during the course of experimental latent tuberculous infection and progressive pulmonary tuberculosis Julio Enrique Castañeda‐Delgado, Rogélio Hernández‐Pando, Carmen J. Serrano, Clinical & Experimental Immunology Cellular SourcesMicrobial PathogensInnate Immune SystemImmunologyPathology	2010	38
IFN-<i>α</i> Boosting of<i> Mycobacterium bovis Bacillus</i> Calmette Güerin-Vaccine Promoted Th1 Type Cellular Response and Protection against<i> M. tuberculosis </i>Infection César Rivas-Santiago, Gloria G. Guerrero BioMed Research International	2017	25

Page 1